MedPath

Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients

Completed
Conditions
Sjögren's Syndrome
Xerostomia
Interventions
Registration Number
NCT00873496
Lead Sponsor
Ege University
Brief Summary

Chronic inflammation that comprises the exocrine glands' function leads to xerophthalmia and xerostomia in Sjögren's syndrome. The oral consequences range widely and they are related to decreased salivary output. Hydroxychloroquine may inhibit cholinesterase activity in salivary glands via interference with antigen processing mechanism, and thus, the investigators' hypothesis was that salivary gland function may be improved if treated with hydroxychloroquine. The effects of hydroxychloroquine on the salivary flow rate, subjective and objective parameters of the patients were also assessed.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • Patients who were recently diagnosed with primary SS according to American-European criteria and who were scheduled for HCQ treatment in Ege University Faculty of Medicine, Department of Rheumatology
Exclusion Criteria
  • Sjögren patients consuming alcohol or tobacco

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
SjögrenHydroxychloroquinePre and post treatment establishment of salivary flow rate, objective and subjective clinical oral complications' severity of the patients using hydroxychloroquine
Primary Outcome Measures
NameTimeMethod
Salivary flow rate, objective and subjective clinical oral complaints2005 Jan-2009 Jan
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ege University School of Dentistry

🇹🇷

Izmir, Bornova, Turkey

© Copyright 2025. All Rights Reserved by MedPath